Estimating biologically relevant parameters under uncertainty for experimental within-host murine West Nile virus infection

Journal of the Royal Society Interface

Volumn 13, Issue 117, 2016, Pages

  Banerjee, Soumya ^a,c   Guedj, Jeremie ^c,e   Ribeiro, Ruy M ^c   Moses, Melanie ^a,b,d   Perelson, Alan S ^c,d  

^a MSC01 1070   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

^c LOS ALAMOS NATIONAL LABORATORY   (United States)

^d SANTA FE INSTITUTE   (United States)

^e INSERM   (France)

Author keywords

Basic reproductive number; Biologically relevant parameters; Ordinary differential equation models; Parameter estimation; West Nile virus infection; Within host viral dynamics

Indexed keywords

DIFFERENTIAL EQUATIONS; DYNAMICS; ESTIMATION; IMMUNE SYSTEM; MAMMALS; ORDINARY DIFFERENTIAL EQUATIONS; UNCERTAINTY ANALYSIS; VIRUSES;

ADAPTIVE IMMUNE RESPONSE; BASIC REPRODUCTIVE NUMBER; BIOLOGICALLY RELEVANT PARAMETERS; HOST IMMUNE RESPONSE; HUMORAL IMMUNE RESPONSE; NONLINEAR COMBINATION; ORDINARY DIFFERENTIAL EQUATION MODELS; WEST NILE VIRUS;

PARAMETER ESTIMATION;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL HOST; HUMORAL IMMUNITY; IMMUNE RESPONSE; INNATE IMMUNITY; MATHEMATICAL MODEL; MOUSE; NONHUMAN; TARGET CELL; VIREMIA; VIRION; VIRUS REPLICATION; WEST NILE FEVER; ANIMAL; DISEASE MODEL; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PHYSIOLOGY; WEST NILE VIRUS;

ANIMALS; DISEASE MODELS, ANIMAL; HOST-PATHOGEN INTERACTIONS; HUMANS; MICE; MICE, KNOCKOUT; VIREMIA; WEST NILE FEVER; WEST NILE VIRUS;

EID: 84969980347     PISSN: 17425689     EISSN: 17425662     Source Type: Journal    
DOI: 10.1098/rsif.2016.0130     Document Type: Article

References (65)

1. Ceausu E et al. 1997 Clinical manifestations in the West Nile virus outbreak. Rom. J. Virol. 48, 3-11.
2. Petersen LR, Marfin AA. 2002 West Nile virus: a primer for the clinician. Ann. Intern. Med. 137, 173-179. (doi:10.7326/0003-4819-137-3-200208060-00009)
3. Sejvar JJ et al. 2003 Neurologic manifestations and outcome of West Nile virus infection. J. Am. Med. Assoc. 290, 511-515. (doi:10.1001/jama.290.4.511)
4. Hayes EB, Komar N, Nasci RS, Montgomery SP, O'Leary DR, Campbell GL. 2005 Epidemiology and transmission dynamics of West Nile virus disease. Emerg. Infect. Dis. 11, 1167-1173. (doi:10.3201/eid1108.050289a)
5. Deardorff E et al. 2006 Introductions of West Nile virus strains to Mexico. Emerg. Infect. Dis. 12, 314-318. (doi:10.3201/eid1202.050871)
6. Komar N, Clark GG. 2006 West Nile virus activity in Latin America and the Caribbean. Rev. Panam. Salud Publica 19, 112-117. (doi:10.1590/S1020-49892006000200006)
7. Lanciotti RS et al. 1999 Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science 286, 2333-2337. (doi:10.1126/science.286.5448.2333)
8. Kilpatrick AM. 2011 Globalization, land use, and the invasion of West Nile virus. Science 334, 323-327. (doi:10.1126/science.1201010)
9. Samuel MA, Diamond MS. 2006 Pathogenesis of West Nile virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion. J. Virol. 80, 9349-9360. (doi:10.1128/JVI. 01122-06)
10. Smithburn KC, Taylor RM, Rizk F, Kader A. 1954 Immunity to certain arthropod-borne viruses among indigenous residents of Egypt. Am. J. Trop. Med. Hyg. 3, 9-18.
11. Suthar MS, Diamond MS, Gale Jr M. 2013 West Nile virus infection and immunity. Nat. Rev. Microbiol. 11, 115-128. (doi:10.1038/nrmicro2950)
12. Diamond MS, Sitati EM, Friend LD, Higgs S, Shrestha B, Engle M. 2003 A critical role for induced IgM in the protection against West Nile virus infection. J. Exp. Med. 198, 1853-1862. (doi:10.1084/jem. 20031223)
13. Diamond MS, Shrestha B, Marri A, Mahan D, Engle M. 2003 B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J. Virol. 77, 2578-2586. (doi:10.1128/JVI.77.4.2578).
14. Shrestha B, Diamond M. 2004 Role of CD8+ T cells in control of West Nile virus infection. J. Virol. 78, 8312-8321. (doi:10.1128/JVI.78.15.8312)
15. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. 1995 Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373, 123-126. (doi:10.1038/373123a0)
16. Perelson AS, Kirschner DE, De Boer R. 1993 Dynamics of HIV infection of CD4+ T cells. Math. Biosci. 114, 81-125. (doi:10.1016/0025-5564(93)90043-A)
17. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD. 1996 HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271, 1582-1586. (doi:10.1126/science.271.5255.1582)
18. Perelson AS, Essunger P, Cao Y, Vesanen M, Hurley A, Saksela K, Markowitz M, Ho DD. 1997 Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 387, 188-191. (doi:10.1038/387188a0)
19. Perelson AS. 2002 Modelling viral and immune system dynamics. Nat. Rev. Immunol. 2, 28-36. (doi:10.1038/nri700)
20. Perelson AS, Ribeiro RM. 2013 Modeling the withinhost dynamics of HIV infection. BMC Biol. 11, 96. (doi:10.1186/1741-7007-11-96)
21. Dixit N, Layden-Almer J, Layden T. 2004 Modelling how ribavirin improves interferon response rates in hepatitis C virus infection. Nature 432, 922-924. (doi:10.1038/nature03153)
22. Neumann AU, Lam NP, Dahari H, Davidian M, Wiley TE, Mika BP, Perelson AS, Layden TJ. 2000 Differences in viral dynamics between genotypes 1 and 2 of hepatitis C virus. J. Infect. Dis. 182, 28-35. (doi:10.1086/315661)
23. Neumann AU, Lam NP, Dahari H, Gretch DR, Wiley TE, Layden TJ, Perelson AS. 1998 Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science 282, 103-107. (doi:10.1126/science.282.5386.103)
24. Rong L, Dahari H, Ribeiro RM, Perelson AS. 2010 Rapid emergence of protease inhibitor resistance in hepatitis C virus. Sci. Transl. Med. 2, 30ra32. (doi:10.1126/scitranslmed.3000544)
25. Rong L, Guedj J, Dahari H, Coffield Jr DJ, Levi M, Smith P, Perelson AS. 2013 Analysis of hepatitis C virus decline during treatment with the protease inhibitor Danoprevir using a multiscale model. PLoS Comput. Biol. 9, e1002959. (doi:10.1371/journal. pcbi.1002959)
26. Guedj J, Dahari H, Rong L, Sansone ND, Nettles RE, Cotler SJ, Layden TJ, Uprichard SL, Perelson AS. 2013 Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life. Proc. Natl Acad. Sci. USA 110, 3991-3996. (doi:10.1073/pnas.1203110110)
27. Tsiang M, Rooney JF, Toole JJ, Gibbs CS. 1999 Biphasic clearance kinetics of hepatitis B virus from patients during adefovir dipivoxil therapy. Hepatology 29, 1863-1869. (doi:10.1002/hep. 510290626)
28. Nowak MA, Bonhoeffer S, Hill AM, Boehme R, Thomas HC, McDade H. 1996 Viral dynamics in hepatitis B virus infection. Proc. Natl Acad. Sci. USA 93, 4398-4402. (doi:10.1073/pnas.93.9.4398)
29. Lewin SR, Ribeiro RM, Walters T, Lau GK, Bowden S, Locarnini S, Perelson AS. 2001 Analysis of hepatitis B viral load decline under potent therapy: complex decay profiles observed. Hepatology 34, 1012-1020. (doi:10.1053/jhep.2001.28509)
30. Baccam P, Beauchemin C, Macken C, Hayden F, Perelson A. 2006 Kinetics of influenza A virus infection in humans. J. Virol. 80, 7590-7599. (doi:10.1128/JVI.01623-05)
31. Smith AM, Perelson AS. 2011 Influenza A virus infection kinetics: quantitative data and models. Wiley Interdiscip. Rev. Syst. Biol. Med. 3, 429-445. (doi:10.1002/wsbm.129)
32. Beauchemin CAA, Handel A. 2011 A review of mathematical models of influenza A infections within a host or cell culture: lessons learned and challenges ahead. BMC Public Health 11, S7. (doi:10.1186/1471-2458-11-S1-S7)
33. Pawelek KA, Huynh GT, Quinlivan M, Cullinane A, Rong L, Perelson AS. 2012 Modeling within-host dynamics of influenza virus infection including immune responses. PLoS Comput. Biol. 8, e1002588. (doi:10.1371/journal.pcbi.1002588)
34. Handel A, Longini IM, Antia R. 2010 Towards a quantitative understanding of the within-host dynamics of influenza A infections. J. R. Soc. Interface 7, 35-47. (doi:10.1098/rsif.2009.0067)
35. Styer L, Kent K, Albright R, Bennett C, Kramer L, Bernard K. 2007 Mosquitoes inoculate high doses of West Nile virus as they probe and feed on live hosts. PLoS Pathog. 3, e132. (doi:10.1371/journal. ppat.0030132)
36. Halstead S, Venkateshan C, Gentry M, Larsen L. 1984 Heterogeneity of infection enhancement of dengue 2 strains by monoclonal antibodies. J. Immunol. 132, 1529-1532.
37. The MathWorks Inc. 2011 MATLAB version 7.13.0.564.
38. Stafford M, Cao Y, Ho D, Corey L. 2000 Modeling plasma virus concentration and CD4+ T cell kinetics during primary HIV infection. J. Theor. Biol. 203, 285-301. (doi:10.1006/jtbi.2000.1076)
39. Herz A, Bonhoeffer S, Anderson RM, May RM, Nowak MA. 1996 Viral dynamics in vivo: limitations on estimates of intracellular delay and virus decay. Proc. Natl Acad. Sci. USA 93, 7247-7251. (doi:10.1073/pnas.93.14.7247)
40. Mittler JE, Sulzer B, Neumann AU, Perelson AS. 1998 Influence of delayed viral production on viral dynamics in HIV-1 infected patients. Math. Biosci. 152, 143-163. (doi:10.1016/S0025-5564(98)10027-5)
41. Holder BP, Beauchemin CA. 2011 Exploring the effect of biological delays in kinetic models of influenza within a host or cell culture. BMC Public Health 11, S10. (doi:10.1186/1471-2458-11-S1-S10)
42. Marti P, Ruiz SR, Marti G, Anjuere F, Vargas HH, Lopezbravo M, Ardavi C. 2002 Dramatic increase in lymph node dendritic cell number during infection by the mouse mammary tumor virus occurs by a CD62 Ldependent blood-borne DC recruitment. Blood 99, 1282-1288. (doi:10.1182/blood.V99.4.1282)
43. Cheeran MC-J, Hu S, Sheng WS, Rashid A, Peterson PK, Lokensgard JR. 2005 Differential responses of human brain cells to West Nile virus infection. J. Neurovirol. 11, 512-524. (doi:10.1080/13550280500384982)
44. Purtha W, Chachu K, Virgin H, Diamond MS. 2008 Early B-cell activation after West Nile virus infection requires alpha/beta interferon but not antigen receptor signaling. J. Virol. 82, 10 964-10 974. (doi:10.1128/JVI.01646-08)
45. Markowitz M, Louie M, Hurley A, Sun E, Di Mascio M, Perelson AS, Ho DD. 2003 A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo. J. Virol. 77, 5037-5038. (doi:10.1128/JVI.77.8.5037-5038.2003)
46. Diamond MS, Shrestha B, Mehlhop E. 2003 Innate and adaptive immune responses determine protection against disseminated infection by West Nile encephalitis virus. Viral Immunol. 16, 259-278. (doi:10.1089/088282403322396082)
47. Lim P-Y, Behr MJ, Chadwick CM, Shi P-Y, Bernard KA. 2011 Keratinocytes are cell targets of West Nile virus in vivo. J. Virol. 85, 5197-5201. (doi:10.1128/JVI.02692-10)
48. Ye C, Abraham S, Wu H, Shankar P, Manjunath N. 2011 Silencing early viral replication in macrophages and dendritic cells effectively suppresses avivirus encephalitis. PLoS ONE 6, e17889. (doi:10.1371/journal.pone.0017889)
49. Hoath SB, Leahy DG. 2003 The organization of human epidermis: functional epidermal units and phi proportionality. J. Invest. Dermatol. 121, 1440-1446. (doi:10.1046/j.1523-1747.2003.12606.x)
50. Dahari H, Layden-Almer JE, Kallwitz E, Ribeiro RM, Cotler SJ, Layden TJ, Perelson AS. 2009 A mathematical model of hepatitis C virus dynamics in patients with high baseline viral loads or advanced liver disease. Gastroenterology 136, 1402-1409. (doi:10.1053/j.gastro.2008.12.060)
51. Riches AC, Sharp JG, Thomas DB, Smith SV. 1973 Blood volume determination in the mouse. J. Physiol. 228, 279-284. (doi:10.1113/jphysiol. 1973.sp010086)
52. Wilson DE, Ruff S. 1999 The Smithsonian book of North American mammals. Washington, DC: Smithsonian Institution Press.
53. Lynn HS. 2001 Maximum likelihood inference for left-censored HIV RNA data. Stat. Med. 20, 33-45. (doi:10.1002/1097-0258(20010115)20:1,33::AIDSIM640.3.0. CO;2-O)
54. Jiang J, Qiu Z, Wu J, Zhu H. 2009 Threshold conditions for West Nile virus outbreaks. Bull. Math. Biol. 71, 627-647. (doi:10.1007/s11538-008-9374-6)
55. Lewis M, Renclawowicz J, van den Driessche P. 2006 Traveling waves and spread rates for a West Nile virus model. Bull. Math. Biol. 68, 3-23. (doi:10.1007/s11538-005-9018-z)
56. Simpson JE, Hurtado PJ, Medlock J, Molaei G, Andreadis TG, Galvani AP, Diuk-Wasser MA. 2012 Vector host-feeding preferences drive transmission of multi-host pathogens: West Nile virus as a model system. Proc. R. Soc. B 279, 925-933. (doi:10.1098/rspb.2011.1282)
57. Pawelek KA, Niehaus P, Salmeron C, Hager EJ, Hunt GJ. 2014 Modeling dynamics of Culex pipiens complex populations and assessing abatement strategies for West Nile virus. PloS ONE 9, e108452. (doi:10.1371/journal.pone. 0108452)
58. Smith AM, Adler FR, McAuley JL, Gutenkunst RN, Ribeiro RM, McCullers JA, Perelson AS. 2011 Effect of 1918 PB1-F2 expression on influenza A virus infection kinetics. PLoS Comput. Biol. 7, e1001081. (doi:10.1371/journal.pcbi.1001081)
59. Hancioglu B, Swigon D, Clermont G. 2007 A dynamical model of human immune response to influenza A virus infection. J. Theor. Biol. 246, 70-86. (doi:10.1016/j.jtbi.2006.12.015)
60. Dahari H, Ribeiro RM, Rice CM, Perelson AS. 2007 Mathematical modeling of subgenomic hepatitis C virus replication in Huh-7 cells. J. Virol. 81, 750-760. (doi:10.1128/JVI.01304-06)
61. Brown KS, Sethna JP. 2003 Statistical mechanical approaches to models with many poorly known parameters. Phys. Rev. E 68, 021904. (doi:10.1103/PhysRevE.68.021904)
62. Gutenkunst RN, Waterfall JJ, Casey FP, Brown KS, Myers CR, Sethna JP. 2007 Universally sloppy parameter sensitivities in systems biology models. PLoS Comput. Biol. 3, 1871-1878. (doi:10.1371/journal.pcbi.0030189)
63. Banerjee S. 2013 Scaling in the immune system. PhD thesis, University of New Mexico, USA.
64. Han C, Chaloner K, Perelson AS. 2002 Bayesian analysis of a population HIV dynamic model. In Case studies in Bayesian statistics. Lecture Notes in Statistics, vol. 167, pp. 223-238. New York, NY: Springer.
65. Komar N, Langevin S, Hinten S, Nemeth N, Edwards E, Hettler D, Davis B, Bowen R, Bunning M. 2003 Experimental infection of North American birds with the New York 1999 strain of West Nile virus. Emerg. Infect. Dis. 9, 311-322. (doi:10.3201/eid0903.020628)